Acadia Pharmaceuticals Inc. · 3 weeks ago
Executive Neuroscience Sales Specialist - San Jose, CA
United States
Full-time
Remote
Entry, Mid, Senior Level
$124K/yr - $155K/yr
1+ years expAcadia Pharmaceuticals is committed to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities. The Neuroscience Sales Specialist will be responsible for achieving sales goals by building strong customer relationships and delivering product education while collaborating with healthcare professionals and stakeholders.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Promote Acadia products to HCPs in person and virtually, providing clinical, disease state, and reimbursement information in a compliant and customer-focused manner
Develop and execute a territory business plan to meet or exceed sales objectives, leveraging market data, customer insights, and quarterly action plans
Establish and maintain strong relationships with HCPs, including key opinion leaders, advocacy organizations, and other healthcare stakeholders
Address customer questions, concerns, and objections using advanced dialogue and selling skills
Tailor approved sales aids, clinical reprints, and brand resources to meet specific customer needs
Partner with internal colleagues (e.g., managed markets, operations, sales training, marketing) to deliver coordinated solutions
Provide guidance on product pricing, reimbursement, and specialty distribution channels, acting as a liaison between customers and the Company for access-related issues
Accurately track and report sales activities, business expenses, and customer interactions in a timely manner
Represent Acadia at conferences, exhibits, and trainings; participate in national, regional, and local meetings as required
Mentor and train new sales specialists as needed, and contribute to cross-functional projects and field strategic insights
Qualification
Required
Bachelor's degree required
Minimum 1-2 years of sales experience in pharmaceutical/healthcare
Minimum 5 years of healthcare sales (2+ in complex/account-based selling) for Senior Specialist
Minimum 12 years of healthcare sales (3+ in complex/account-based selling) for Executive Specialist
Demonstrated advanced selling skills, leadership abilities, and business acumen
Proven success in influencing diverse HCP audiences across multiple care settings
Strong interpersonal, communication, and negotiation skills
Ability to work independently, adapt to change, and deliver consistently high results
Must reside within the territory (or within 30 miles of its border) and possess a valid driver's license with an acceptable driving record
Ability to meet travel requirements, including significant driving and overnight stays; air travel as needed
Must comply with vaccination requirements for HCP office access, long-term care facilities, and medical conferences
Deep understanding of neuroscience disease states, Acadia products, and local/regional market dynamics
Ability to serve as a trusted resource in the medical community
Proficiency in Microsoft Office and virtual engagement platforms (e.g., Zoom, WebEx)
Strong grasp of payer dynamics, including Part D and specialty pharmacy/hub distribution
Preferred
Life sciences preferred
Neuroscience preferred
Experience in complex/account-based selling environments preferred
Benefits
Competitive base, bonus, new hire and ongoing equity packages
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance
Company
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$811.73MKey Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M
Leadership Team
Catherine Adams
Chief Executive Officer
Steve Davis
President and CEO
Recent News
2025-11-20
Company data provided by crunchbase